• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid (CAS No. 1228571-37-6)

(3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid (CAS No. 1228571-37-6) is a chiral amino acid derivative that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, including a chiral center and a 2,5-difluorophenyl substituent, which contribute to its potential therapeutic applications.

The chiral nature of (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid is crucial for its biological activity and selectivity. Chirality plays a vital role in the interaction of molecules with biological targets, often leading to enhanced efficacy and reduced side effects. The (S) configuration of this compound ensures that it can selectively bind to specific receptors or enzymes, making it a valuable candidate for drug development.

Recent studies have highlighted the potential of (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid in various therapeutic areas. One notable application is in the treatment of neurological disorders. Research has shown that this compound can modulate the activity of certain neurotransmitters, potentially offering new avenues for the treatment of conditions such as Parkinson's disease and Alzheimer's disease. The ability to influence neurotransmitter systems is particularly important given the growing prevalence of neurological disorders and the need for more effective treatments.

In addition to its neurological applications, (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid has also been investigated for its anti-inflammatory properties. Inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (IBD) are characterized by chronic inflammation, which can lead to significant morbidity and reduced quality of life. Studies have demonstrated that this compound can inhibit key inflammatory pathways, suggesting its potential as an anti-inflammatory agent.

The pharmacokinetic properties of (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid have also been extensively studied. Its high solubility and favorable absorption characteristics make it suitable for various routes of administration, including oral and intravenous delivery. These properties are essential for ensuring that the compound reaches its intended target in sufficient concentrations to exert its therapeutic effects.

Clinical trials are currently underway to evaluate the safety and efficacy of (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid in human subjects. Preliminary results have been promising, with the compound demonstrating good tolerability and a favorable safety profile. These findings are encouraging and suggest that this compound has the potential to become a valuable addition to the therapeutic arsenal for treating various diseases.

The synthesis of (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid has been optimized through various synthetic routes, each with its own advantages and challenges. One common approach involves the use of chiral auxiliaries or catalysts to ensure the formation of the desired (S) enantiomer. Advances in asymmetric synthesis have significantly improved the efficiency and yield of these processes, making large-scale production more feasible.

In conclusion, (3S)-3-Amino-3-(2,5-difluorophenyl)propanoic Acid (CAS No. 1228571-37-6) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features, coupled with its favorable pharmacological properties, make it an attractive candidate for further development. Ongoing research and clinical trials will continue to elucidate its full therapeutic potential and pave the way for new treatments in various medical fields.

• 151911-32-9((S)-3-Amino-3-(2-fluoro-phenyl)-propionic acid)
• 682804-04-2(3-Amino-3-(2,3-difluorophenyl)propanoic acid)
• 117391-49-8(3-Amino-3-(2-fluorophenyl)propanoic Acid)
• 151911-22-7((R)-3-Amino-3-(2-fluoro-phenyl)-propionic acid)
• 773122-52-4(3-amino-3-(2,5-difluorophenyl)propanoic acid)
• 1270156-95-0((3S)-3-Amino-3-(2,6-difluorophenyl)propanoic acid)
• 412925-23-6(3-amino-3-(2,4-difluorophenyl)propanoic Acid)
• 773126-27-5(3-AMINO-3-(2-FLUORO-5-METHYLPHENYL)PROPANOIC ACID)
• 1228561-39-4((3S)-3-amino-3-(2,3-difluorophenyl)propanoic acid)
• 612532-20-4( )